FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Wolfgang Meissner

Research Profile

Chemicals & Drugs

Physiology

Living Beings

Mouse

Anatomy

Phenomena

Co-author Network

Publications

TOP 3
Josefine Stockert; Alexander Wolf; Sabine Müller-Brüsselbach; Evelyn Schnitzer; Florian Finkernagel; Kerstin Kaddatz; Michael Kracht; Wolfgang Meissner; Rolf Mueller
Regulation of TAK1/TAB1-Mediated IL-1β Signaling by Cytoplasmic PPARβ/δ.
Sonja Lieber; Wolfgang Meissner; Till Adhikary; Wibke E Diederich; Sabine Müller-Brüsselbach; Simone Naruhn; Frithjof Scheer; Rolf Mueller
(Z)-2-(2-bromophenyl)-3-{[4-(1-methyl-piperazine)amino]phenyl}acrylonitrile (DG172): an orally bioavailable PPARβ/δ-selective ligand with inverse agonistic properties.
Till Adhikary; Kerstin Kaddatz; Florian Finkernagel; Anne Schönbauer; Wolfgang Meissner; Maren Scharfe; Michael Jarek; Helmut Blöcker; Sabine Müller-Brüsselbach; Rolf Mueller
Genomewide analyses define different modes of transcriptional regulation by peroxisome proliferator-activated receptor-β/δ (PPARβ/δ).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Wolfgang Meissner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Josefine Stockert; Alexander Wolf; Sabine Müller-Brüsselbach; Evelyn Schnitzer; Florian Finkernagel; Kerstin Kaddatz; Michael Kracht; Wolfgang Meissner; Rolf Mueller
Regulation of TAK1/TAB1-Mediated IL-1β Signaling by Cytoplasmic PPARβ/δ.
PloS one 2013;8(4):e63011.
2012: Sonja Lieber; Wolfgang Meissner; Till Adhikary; Wibke E Diederich; Sabine Müller-Brüsselbach; Simone Naruhn; Frithjof Scheer; Rolf Mueller
(Z)-2-(2-bromophenyl)-3-{[4-(1-methyl-piperazine)amino]phenyl}acrylonitrile (DG172): an orally bioavailable PPARβ/δ-selective ligand with inverse agonistic properties.
Journal of medicinal chemistry 2012;55(6):2858-68.
2011: Till Adhikary; Kerstin Kaddatz; Florian Finkernagel; Anne Schönbauer; Wolfgang Meissner; Maren Scharfe; Michael Jarek; Helmut Blöcker; Sabine Müller-Brüsselbach; Rolf Mueller
Genomewide analyses define different modes of transcriptional regulation by peroxisome proliferator-activated receptor-β/δ (PPARβ/δ).
PloS one 2011;6(1):e16344.
2011: Josefine Stockert; Till Adhikary; Kerstin Kaddatz; Florian Finkernagel; Wolfgang Meissner; Sabine Müller-Brüsselbach; Rolf Mueller
Reverse crosstalk of TGFβ and PPARβ/δ signaling identified by transcriptional profiling.
Nucleic acids research 2011;39(1):119-31.
2010: Kerstin Kaddatz; Till Adhikary; Florian Finkernagel; Wolfgang Meissner; Sabine Müller-Brüsselbach; Rolf Mueller
Transcriptional profiling identifies functional interactions of TGF β and PPAR β/δ signaling: synergistic induction of ANGPTL4 transcription.
The Journal of biological chemistry 2010;285(38):29469-79.
2010: Simone Naruhn; Wolfgang Meissner; Till Adhikary; Kerstin Kaddatz; T Klein; Bernhard Watzer; Sabine Müller-Brüsselbach; Rolf Mueller
15-hydroxyeicosatetraenoic acid is a preferential peroxisome proliferator-activated receptor beta/delta agonist.
Molecular pharmacology 2010;77(2):171-84.
2009: Susanne Wiegand; Branka Dakic; Ariane F E Rath; Galina Makarova; Carolina Sterz; Wolfgang Meissner; Michael Bette; Jürgen Adamkiewicz; Sabine Müller-Brüsselbach; Rolf Mueller; Jochen A Werner; Robert Mandic
The rotamase Pin1 is up-regulated, hypophosphorylated and required for cell cycle progression in head and neck squamous cell carcinomas.
Oral oncology 2009;45(10):e140-9.
2008: Markus Rieck; Wolfgang Meissner; Simone Ries; Sabine Müller-Brüsselbach; Rolf Mueller
Ligand-mediated regulation of peroxisome proliferator-activated receptor (PPAR) beta/delta: a comparative analysis of PPAR-selective agonists and all-trans retinoic acid.
Molecular pharmacology 2008;74(5):1269-77.
2007: Markus Rieck; Lena Wedeken; Sabine Müller-Brüsselbach; Wolfgang Meissner; Rolf Mueller
Expression level and agonist-binding affect the turnover, ubiquitination and complex formation of peroxisome proliferator activated receptor beta.
The FEBS journal 2007;274(19):5068-76.
2007: Sabine Müller-Brüsselbach; Martin Kömhoff; Markus Rieck; Wolfgang Meissner; Kerstin Kaddatz; Jürgen Adamkiewicz; Boris Keil; Klaus Jochen Klose; Roland Moll; Andrew D Burdick; Jeffrey M Peters; Rolf Mueller
Deregulation of tumor angiogenesis and blockade of tumor growth in PPARbeta-deficient mice.
The EMBO journal 2007;26(15):3686-98.
2006: Tanja Fauti; Sabine Müller-Brüsselbach; Mihaela Kreutzer; Markus Rieck; Wolfgang Meissner; Ulf R Rapp; Horst Schweer; Martin Kömhoff; Rolf Mueller
Induction of PPARbeta and prostacyclin (PGI2) synthesis by Raf signaling: failure of PGI2 to activate PPARbeta.
The FEBS journal 2006;273(1):170-9.
2004: Stephan Weser; Christin Gruber; Heike M Hafner; Martin Teichmann; Robert G Roeder; Klaus H Seifart; Wolfgang Meissner
Transcription factor (TF)-like nuclear regulator, the 250-kDa form of Homo sapiens TFIIIB", is an essential component of human TFIIIC1 activity.
The Journal of biological chemistry 2004;279(26):27022-9.
2003: Stephan Weser; Jana Riemann; Klaus H Seifart; Wolfgang Meissner
Assembly and isolation of intermediate steps of transcription complexes formed on the human 5S rRNA gene.
Nucleic acids research 2003;31(9):2408-16.
2002: Thorsten Bieber; Wolfgang Meissner; Sawa Kostin; Axel Niemann; Hans-Peter Elsasser
Intracellular route and transcriptional competence of polyethylenimine-DNA complexes.
Journal of controlled release : official journal of the Controlled Release Society 2002;82(2-3):441-54.
2002: Wolfgang Meissner; Renate Thomae; Klaus H Seifart
The activity of transcription factor IIIC1 is impaired during differentiation of F9 cells.
The Journal of biological chemistry 2002;277(9):7148-56.
2001: Wolfgang Meissner; H Rothfels; B Schäfer; Klaus H Seifart
Development of an inducible pol III transcription system essentially requiring a mutated form of the TATA-binding protein.
Nucleic acids research 2001;29(8):1672-82.
2000: Stephan Weser; M Bachmann; Klaus H Seifart; Wolfgang Meissner
Transcription efficiency of human polymerase III genes in vitro does not depend on the RNP-forming autoantigen La.
Nucleic acids research 2000;28(20):3935-42.